tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amicus price target raised to $22 from $21 at UBS

UBS raised the firm’s price target on Amicus (FOLD) to $22 from $21 and keeps a Buy rating on the shares. While 2025 guidance for Pompe disease was lowered, the long-term is on track and the Dimerix deal is a positive, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1